Open AccessEfficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis
Author(s) -
Deep Dutta,
Saptarshi Bhattacharya,
Arvind Krishnamurthy,
Lokesh Kumar Sharma,
Meha Sharma
Publication year - 2020
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_418_20
Subject(s) - sitagliptin , medicine , linagliptin , postprandial , alogliptin , glycemic , dipeptidyl peptidase 4 , placebo , adverse effect , dipeptidyl peptidase 4 inhibitor , type 2 diabetes mellitus , diabetes mellitus , gastroenterology , type 2 diabetes , insulin , endocrinology , alternative medicine , pathology